Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-18

Clinical Trial Update: Impact on the Intestinal Microbiota of Treatment With Ceftriaxone in Women's Acute Community Pyelonephritis [Phase 4]

View source ↗

Summary

Phase 4 trial update examining how ceftriaxone treatment affects the intestinal microbiota in acute pyelonephritis in women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Pyelonephritis Acute | Phase 4 | Status: COMPLETED